Browsing publications by Kieran O'Toole

Newcastle AuthorsTitleYear
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Daniel Williamson
Dr David Hamilton
Kieran O'Toole
et al.		Epigenetic sub-classification and risk-stratification of medulloblastoma using DNA methylomics2012
Dr Sarra Ryan
Dr Ed Schwalbe
Mike Cole
Yuan Lu
Dr Meryl Lusher
et al.		MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma2012
Dr Simon Pridgeon
Dr Rakesh Heer
Gordon Taylor
Professor Herbie Newell
Kieran O'Toole
et al.		Thiothymidine combined with UVA as a potential novel therapy for bladder cancer2011
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Meryl Lusher
Kieran O'Toole
Sarah Nicholson
et al.		DNA methylomics identifies clinically significant epigenetic subgroups of medulloblastoma2010
Dr Joyce Nutt
Kieran O'Toole
Dr Fiona Black
Mike Cole
Professor Ruth Plummer
et al.		Expression of methylthioadenosine phosphorylase (MTAP) in malignant pleural mesothelioma (MPM) and its implication for pemetrexed-based chemotherapy2010
Dr Jane Carr-Wilkinson
Kieran O'Toole
Angela Baker
Julian Board
Mike Cole
et al.		High frequency of p53/MDM2/p14ARF pathway abnormalities in relapsed neuroblastoma2010
Professor Steven Clifford
Dr Sarra Ryan
Mike Cole
Dr Meryl Lusher
Kieran O'Toole
et al.		MYC gene family amplification and expression in childhood medulloblastoma: Biological significance and utility for high-risk disease stratification2010
Dr Joyce Nutt
Kieran O'Toole
Dr Fiona Black
Amy Quinn
Professor Alan Calvert
et al.		The role of folate receptor alpha (FR alpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy2010
Professor Steven Clifford
Kieran O'Toole
Professor David Ellison
Chromosome 1q gain is not associated with a poor outcome in childhood medulloblastoma: requirements for the validation of potential prognostic biomarkers2009
Dr Joyce Nutt
Kieran O'Toole
Dr Fiona Black
Professor Ruth Plummer
Professor Alan Calvert
et al.		Expression of folate receptor alpha (FRa) in malignant pleural mesothelioma patients by immunohistochemistry: a clinico-pathological analysis2009
12